Skip to content

← All stories

Markets

Biohaven Pharma stock price target raised to $23 by RBC Capital

1 source ·1 article ·1h ago RBC Bearings

Covered by 1 outlet

All coverage · 1 article

Investing.com News ·1h ago

Biohaven Pharma stock price target raised to $23 by RBC Capital